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The aquaporin family of water channels in kidney: An update on
physiology and pathophysiology of aquaporin-2. The long-standing prob-
lem of membrane water transport has been advanced by the recognition of
a new family of water transport proteins, the "aquaporins" [1—3]. Not
surprisingly, water transport is a major process in kidney physiology, and
the biology of aquaporins is most thoroughly understood in that organ. We
reviewed in detail the status of aquaporins in the kidney only one year ago
[41, but the subsequent progress has dictated the need for an update. This
seems especially appropriate in honor of the 100th birthday of Homer
Smith, the pioneer whose foresight initiated this field.
Vasopressin plays a key role in the regulation of water metab-
olism. Under normal conditions the kidney collecting duct is
extremely sensitive to vasopressin. Thus, during extreme antidi-
uresis as a consequence of high vasopressin levels, water excretion
can be reduced by two order of magnitudes relative to water
excretion in conditions with low vasopressin levels, without affect-
ing the rate of solute excretion. Two fundamentally different
mechanisms allow for this regulation, and they are both based on
the modulation of collecting duct water permeability: short-term,
regulatory, and long-term, adaptive, mechanisms. Both appear to
involve aquaporin-2 water channels and vasopressin. Recent
studies have also underscored the importance of aquaporin-2 in
the pathophysiology of diabetes insipidus. This review focuses on
long-term regulation of aquaporin-2 and its involvement in the
pathophysiology of nephrogenic diabetes insipidus.
Vasopressin-mediated expression of aquaporin-2
(long-term regulation)
For many years it has been recognized that maximal urinary
concentrating ability can be conditioned by long-term alterations
in water intake [5]. We have proposed that this long-term
conditioning effect is due in part to adaptations in the renal
collecting duct that increase the osmotic water permeability
independent of the short-term action of vasopressin [5, 6]. In
support of this view, we have demonstrated that restriction of fluid
intake in rats for 24 hours or more results in a sustained increase
in water permeability in isolated perfused IMCD segments de-
spite the absence of AVP in the peritubular bath [6]. In contrast,
the urea permeability of the IMCD segments was not increased,
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suggesting that the effect was selective for collecting duct water
permeability. An adaptational increase in IMCD water perme-
ability in response to water restriction has been confirmed in
several studies [7—9]. Recent studies have focused on the mecha-
nism of this adaptation. Prior to our analysis using specific
antibodies against aquaporin-2 (AQP2), we conducted freeze-
fracture electron microscopy in isolated perfused tubules and
demonstrated that IMCDs from water-restricted rats both mani-
fest a high vasopressin-independent water permeability and con-
tained a large number of characteristic intramembrane particle
clusters in the apical plasma membrane [7]. These clusters are
believed to contain vasopressin regulated water channels [10].
Thus, we reached the preliminary conclusion that long-term
conditioning of collecting duct water permeability was likely to be
due to the presence in the apical plasma membrane of the same
type of water channels that are regulated acutely by vasopressin.
With the availability of specific polyclonal antibodies to AQP2 we
were able to test this hypothesis directly.
AQP2 [11] is localized predominantly in the apical plasma
membrane and in subapical vesicles in kidney collecting duct
principal cells [12]. Using immunoblotting and immunocytochem-
istry, we have demonstrated that water restriction in rats for 24
hours or more results in a marked increase in the quantity of
AQP2 protein in cortical and inner medullasy collecting duct
principal cells [12]. This has subsequently been confirmed by use
of immunoblotting, immuno-ELISA and Northern blotting tech-
niques [13—15]. An increase in AQP2 expression was noted both in
the apical plasma membrane and in intracellular vesicles, indicat-
ing that the adaptation is due to an overall up-regulation of AQP2
expression. Experiments in Brattleboro rats, which manifest an
absolute lack of circulating vasopressin, showed that vasopressin
infusions via osmotic minipumps for five days result in a marked
increase in AQP2 expression in both inner medullary and cortical
collecting ducts (Fig. 1 [161). Quantitative immunoblotting dem-
onstrated a threefold increase in the amount of AQP2 protein in
the inner medulla and a parallel threefold increase in the osmotic
water permeability of isolated perfused collecting ducts from
these animals (Fig. 2) [16]. This provided direct evidence that
AQP2 expression is regulated by vasopressin (directly or indi-
rectly) and that AQP2 is the predominant vasopressin regulated
water channel. Deen et al, in an elegant study [17] found
mutations in the AQP2 gene (resulting in non-functional water
channels) in patients suffering from severe primary nephrogenic
1718
Nielsen et a!: Aquaporin water channels 1719
Fig. 1. Effect of long-term infusion of vasopressin. Brattleboro rats were infused for five days with vehicle (A) or AVP (B) in minipumps. AQP2 labeling
is exclusively associated with the apical domains of cortical collecting duct principal cells (arrows). The labeling was significantly increased after
vasopressin treatment. Reproduction of this figure in color is made possible by a grant from Leica.
Fig. 4. Effect of lithium on AQP2 expression: immunofluorescence microscopy of AQP2- labeling in rat inner medulla. (A) In control animals, there is
conspicuous labeling of collecting duct principal cells (arrows), whereas intercalated cells are unlabeled (arrowhead). (B) Lithium treatment for 25 days
virtually abolishes AQP2-labeling (arrow). Adapted from [22]. Reproduction of this figure in color is made possible by a grant from Leica.
diabetes insipidus (NDI). Later Sasaki and associates demon-
strated that treatment of rats with vasopressin receptor blockers
resulted in reduced expression of aquaporin-2, providing further
evidence that the expression of AQP2 is tightly regulated by
vasopressin [13]. The above studies unequivocally demonstrate
that AQP2 is essential for renal concentrating ability.
Recent studies have demonstrated that thirsting rats strongly
up-regulate the levels of AQP2 mRNA in their renal medullas [18,
19], suggesting that increases in AQP2 protein levels may be due
to transcriptional regulation. It is not presently known whether
the increase in AQP2 mRNA is due to increased transcription of
the AQP2 gene or to increased stability of AQP2 mRNA in
thirsted animals. However, cloning of the 5 '-flanking region of the
AQP2 gene has revealed a putative cAMP-regulatory element
(CRE), which may be involved in the vasopressin-induced in-
creases in AQP2 transcription rate [20].
Aquaporin-2 and acquired forms of nephrogenic
diabetes insipidus
The studies in Brattleboro rats, which revealed low levels of
AQP2 in association with extreme polyuria [16], and the demon-
stration of mutated non-functional AQP2 in human NDI patients
[17], triggered efforts to examine the role of AQP2 expression in
certain acquired forms of nephrogenic diabetes insipidus (NDI).
Acquired ND! is much more common than the relatively rare
primary forms of DI [21], and the most common form is lithium-
induced ND!. Lithium, used as drug for treatment of manic-
depressive illness, is prescribed to about 0.1% of the population,
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Fig. 2. Effect of long-term infusion of
vasopressin. In Brattleboro rats infused for five
days with AVP in minipumps, total AQP2
expression increased by threefold in the inner
medulla (A). There was a parallel increase in
the maximum water permeability of isolated
perfused collecting ducts after acute stimulation
with vasopressin (B). Adapted from [16].
Days of lithium treatment
Fig. 3. Effect of lithium on AQP2 levels and urine osmolarity. Lithium treatment caused a dramatic decrease in AQP2 expression at 25 days, as shown
by immunoblotting (A). Densitometry (B) revealed a progressive decrease in AQP2, and exceeded 95% at day 25. There was a parallel decline in urine
osmolarity (C). Adapted from [22].
and polyuria is seen as an important side effect in about 1/5 of the
patients. In a recent study [221, we found that lithium treatment of
rats for 10 and 25 days was associated with a marked down-
regulation of AQP2 expression to levels as low as 4% of control
levels (Fig. 3 and 4). This coincided with the development of
severe polyuria [16], consistent with an important role of the
decreased levels of AQP2 in the development of NDI.
Clinical studies have documented a persisting defect of urinary
concentrating ability and polyuria after cessation of lithium
treatment. The underlying molecular basis for this has been
unclear. Cessation of lithium treatment for seven days only
partially restored AQP2 levels and urinary osmolality, consistent
with the clinical findings of slow recovery of lithium-induced
concentrating defects [22]. Thus, the slow recovery of AQP2
expression may play a profound role in long-term regulation of
collecting duct water reabsorption, and hence, re-establishment of
normal levels of diuresis. These studies, as well as the studies
showing changes in AQP2 expression induced by changes in
hydration status, may also help explain many conditions where
restoration of the urinary concentrating ability lags significantly
behind the correction of the primary underlying cause of polyuria/
ND! [21].
To further support the view that reduced levels of AQP2 may
be a general factor in acquired forms of NDI from a variety of
causes, we examined AQP2 expression in the setting of hypoka-
lemia or bilateral ureteral obstruction, two known causes of ND!.
Potassium deprivation for 11 days resulted in a reduction in AQP2
levels in inner medullary collecting ducts to approximately 25%, in
parallel with a 200 to 400% increase in urine production [231.
Thus, although not as profoundly reduced as seen after lithium
therapy, a decrease in AQP2 expression was noted in association
with the hypokalemia-induced polyuria. In addition a modest
concentrating defect was determined in response to a period of 12
or 24 hours of thirsting, consistent with previous observations
demonstrating that AQP2 is necessary for urinary concentrating
ability [16, 171. A return to a normal diet was also associated with
normalization of AQP2 levels and urine output.
Polyuria after release of ureteral obstruction is often seen in
patients with urological disorders. Such disorders are a frequent
cause of urinary concentrating defects, so it became relevant to
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Fig. 5. Acute effect of vasopressin is superimposed on long-term changes in
AQP2 expression. In animals thirsted for 48 hours (left panel), AQP2 was
approximately equally distributed between the plasma membrane (PM)
and intracellular vesicle (ICV) fraetions. This ratio is similar to that seen
in untreated rats, but prolonged thirsting is known to increase total AQP2
expression. Following water loading, most AQP2 is moved to the intra-
cellular vesicics (center panel). After acute vasopressin stimulation (right
panel), many water channels are moved back to the plasma membrane
fraction. Thus the large reserve of AQP2 in these animals, caused by
long-term conditioning, allows an enhanced response to an acute chal-
lenge. Adapted from [30].
examine AQP2 expression in such conditions. Frøkier et al
examined the role of bilateral ureteral obstruction on AQP2
expression in rat kidney inner medulla [24]. AQP2 levels were
already markedly reduced, to approximately 25%, after 24 hours
of bilateral ureteral obstruction (that is, prior to release of
obstruction). The release of obstruction was followed by develop-
ment of severe polyuria. This inital postobstructive polyuria is
believed to be predominantly osmotically induced. However, the
polyuria persisted for several days after release of obstruction, and
this is consistent with the continuing low levels of AQP2 observed.
Seven days after release of obstruction, the diuresis was almost
normalized when rats were allowed free access to water. However,
when thirsted, the rats still displayed a significant impairment in
concentrating capacity, which is consistent with the observation
that AQP2 levels were only partially restored (FrØkir, Marples,
Kiepper and Nielsen, unpublished data). Thus, the slow recovery
in AQP2 expression may be critically involved in the slow recovery
of urinary concentrating ability in various causes acquired NDI. In
the three forms of ND! we examined, it appeared that there was
a proportional decrease in AQP2 levels when compared to the
degree of polyuria associated with the conditions, further support-
ing the view that there is a causative link between levels of AQP2
and polyuria in these conditions.
The studies described above revealed that there was an identi-
cal decrease in AQP2 levels both in inner medullary collecting
ducts both after hypokalemia and lithium treatment. This indi-
cates that interstitial tonicity may not be important in the regula-
tion of AQP2 expression. This is further substantiated by the lack
of major changes in AQP2 expression after 24 hours of furo-
semide treatment (Marples et al, unpublished observations) and
the failure of five-day furosemide treatment to blunt the the
upregulatory response to AVP infusion [25]. Thus, there is
considerable evidence to support the view that interstitial tonicity
does not have a major influence in inducing AQP2 expression.
However, Sasaki and associates recently demonstrated that hyper-
tonicity itself increases the promotor activity of human AQP2
gene using a CAT assay after transfection of OMCD cells with the
construct [26]. Thus an effect of tonicity cannot be ruled out
completely, although the whole animal experiments suggest that
tonicity plays only a minor role.
Recently, Apostol et al demonstrated an 87% decrease in
AQP2 in puromycin aminonucleoside (PAN) nephrosis in associ-
ation with a marked decrease in the urinary concentrating capac-
ity (but no polyuria). Thus, changes in AQP2 expression may also
be of particular importance in conditions having both dilutional
and concentrating defects as seen in nephrotic syndromes and in
conditions with hyponatremia (see below). The down-regulation
during PAN nephrosis was seen despite markedly elevated levels
of vasopressin. Also, bilateral ureteral obstruction has been shown
to be associated with increased levels of vasopressin. Thus, the
direct mechanism for the down-regulation of AQP2 remains to be
established in the above described conditions. Although vasoprcs-
sin directly induces expression of AQP2 [16], as described above,
changes in hydration status of normal rats also significantly alter
the levels of AQP2 expression [12, 13]. However, it remains to be
documented whether thirsting/water loading-induced changes are
mediated entirely via changes in vasopressin levels/sensitivity, or
whether vasopressin-independent mechanisms may also have a
role. In this context, Marples et al [221 found that thirsting of
lithium treated rats induced a considerably greater increase in
AQP2 expression than did seven days of dDAVP treatment
(which effectively increased urine osmolality). In contrast, thirst-
ing was not very effective in inducing a redistribution of AQP2 to
the apical plasma membrane, while dDAVP was effective. This
suggests that the thirsting-induced increase in AQP2 may be at
least partly due to a mechanism other than that stimulated by
vasopressin. Further studies are necessary to clarify these issues.
Sasaki et al demonstrated that AQP2 can be detected in human
urine [27], and Kanno et al recently exploited this observation by
examining the urinary excretion of AQP2 in normal individuals
and in patients suffering from NDI [28]. Although the cellular
mechanism for AQP2 excretion remain unknown, these studies
indicate that normal individuals had significantly increased excre-
tion of AQP2 in response to vasopressin treatment, whereas
X-linked ND! and central DI patients did not. Thus, reduced
levels of AQP2 are also seen in humans suffering from various
forms of DI, extending the initial observations by Deen et al [171.
Vasopressin regulated translocation of Aquaporin-2 (short-term
regulation): Superimposed effect of long-term regulation
In vitro arid in vivo studies documented a translocation of AQP2
from intracellular vesicles to the apical plasma membrane, which
was paralleled by an increase in water reabsorption [29] and urine
osmolarity [30]. Two other groups have recently reported similar
results [31, 32]. Phosphorylation of AQP2 directly by PKA had
only a marginal effect on water conductance [33], or no effect at all
[34]. Thus, translocation of AQP2 appears to be the major cellular
mechanism by which vasopressin induces an increase in collecting
duct water permeability and hence water conservation, supporting
the "shuttle hypothesis" as originally proposed by Wade, Stetson
48 hr
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and Lewis [35]. Vasopressin binds to heterotrimeric G-protein-
coupled vasopressin receptors (V2-receptors [36], which activate
adenylyl cyclase to produce cAMP serving as a second messenger
[37]. The cellular effects of cAMP involve activation of protein
kinase A, which phosphorylates various proteins [38], presumably
also regulatory proteins, which in turn result in an increase in the
water permeability. However, PKA effects may also directly or
indirectly induce increased expression, providing a direct link
between long-term and short-term effects. To test if long-term
regulatory mechanisms may influence the short-term effects of
vasopressin we used different pretreatment protocols including
thirsting and water loading of rats [30]. The results revealed that
changes in hydration status influenced markedly the magnitude of
the vasopressin-induced shift in AQP2 localization. For example,
the response to dDAVP was markedly enhanced after initial
dehydration (to increase AQP2 levels) followed by water loading
(to maximize intracellular localization). After this manipulation,
the dDAVP-mediated response increased plasma membrane lev-
els of AQP2 by several-fold (Fig. 5) [30]. These data indicate that
short-term and long-term mechanisms are superimposed.
Expression in kidney during fetal development
Expression of aquaporins during fetal developement is hypoth-
esized to be critical for the development of specific organ func-
tions, such as in kidney and lung. AQPI is first identified in
circulating red cells at the third postnatal day, which correlates
directly with acquisition of high osmotic water permeability [39].
Coincident with AQP1 expression in rat red cells after birth, a
marked increase in AQP1 expression in rat kidney proximal
tubules and thin descending limbs was demonstrated [39] at the
time of development of renal concentrating ability. Induction of
AQP2 during fetal development follows a similar time course,
although AQP2 appears to be expressed at low levels earlier in
development [32, 401. Urinary concentrating capacity increased
markedly during development from postnatal day 10 to day 40,
and concomitantly a marked increase in AQP2 mRNA and AQP2
protein (3.5-fold) was seen in this period [40]. Moreover, Yasui et
a! found a marked effect of betamethasone, which increases both
urinary osmolality, renal AQP2 mRNA (2-fold) and AQP2 pro-
tein (7-fold), [401. This was only seen in infant rats; no increase
was observed in 40-day-old rats. The mechanism for the long-term
induction of AQP2 by corticosteroids has not been established,
although the time courses appear to suggest an indirect effect of
betamethasone. An important role of glucocorticoids for aqua-
porin expression and organ development, was also concluded by
King et al. In lung, a marked increase in AQP1 was observed in
the perinatal period, and betamethasone treatment markedly
increased AQP1 levels, indicating a role of AQPI in the develop-
ment of lung in preparation for air breathing [41].
AQP2 expression in hyponatremic states with water retention
As described [42], conditions with hyponatremia can be cate-
gorized, according to the state of the extracellular fluid (ECF)
volume. An important group consists of disorders in which there
is a large excess of ECF, with the development of ascites, as seen
in association with cardiac failure, cirrhosis, and nephrotic syn-
drome. In these conditions, water retention is associated with
increased release of AVP, and this would be expected to increase
AQP2 levels in the collecting duct via the long-term regulatory
mechanisms discussed above. In turn, the increased AQP2 levels
may contribute to the impairment in the ability of the kidney to
excrete water. Preliminary evidence to support this comes from
recent findings of Asahina et al [43], observing an increase in
AQP2 protein levels in the inner medulla of cirrhotic rats. In other
conditions, in which ECF volume is reduced (for example due to
excessive diuretic use or osmotic diuresis) increased levels of
vasopressin, and thus AQP2, would be expected. Preliminary
observations in streptozotocin treated rats with diabetes mellitus
reveals a significant upregulation of AQP2 in kidney inner me-
dulla (Marples, Rasch, Knepper and Nielsen, unpublished obser-
vations).
Further studies will undoubtedly focus on changes of aquaporin
expression in various pathological conditions including congestive
heart failure, cirrhosis, nephrotic syndrome, hydronephrosis, ce-
rebral edema, etc., and such studies may reveal essential informa-
tion about the physiology and pathophysiology of AQPs.
Conclusions
We have attempted here to summarize the recent studies which
aimed at clarifying the long-term processes by which AQP2 is
regulated in the collecting duct. The molecular explanations for
poorly understood clinical disorders of renal collecting duct are
emerging. As is often the case in physiology, the details are
extremely complex and yet the basic principles are simple. This is
certainly true for the aquaporins.
Reprint requests to SØren Nielsen, M.D., Ph.D., Department of Cell
Biology, Institute of Anatomy, DK-8000 Aarhus C, University of Aarhus,
Aarhus, Denmark.
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